About half of patients with neuroblastoma are classified as having high-risk disease, by a combination of factors including age at diagnosis, extent of disease, histological findings, and cytogenetic characteristics such as MYCN amplification and DNA ploidy. The gene discussed is MYCN; the disease is neuroblastoma.